Other authors have confirmed the existence of three different subgroups among IDHmut gliomas, underlying the key role of other epigenetic modulators apart from mutant IDH1/2, like REST (RE1 Silencing Transcription Factor), in some of these subgroups [51]. The gene discussed is IDH1; the disease is central nervous system cancer.